EpiPen Buyers Can't Appeal Order Yet In Antitrust Case

By Matthew Perlman (October 26, 2021, 4:30 PM EDT) -- EpiPen buyers can't immediately appeal an order that dismissed racketeering claims from its case accusing Mylan of scheming to inflate the price of the emergency allergy treatment, a Kansas federal judge has ruled.

U.S. District Judge Daniel D. Crabtree issued an order on Monday denying a motion from the buyers seeking to certify part of a June ruling for interlocutory appeal in a case in which Mylan is set to face trial on state antitrust claims early next year.

The buyers contended that the court was wrong to grant summary judgment in Mylan's favor on their racketeering claim, arguing that there...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!